Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, Yuparat Jantraphakorn, Natthakarn Mingngamsup, Paul V Licciardi, Kulkanya Chokephaibulkit
doi: https://doi.org/10.1101/2022.03.03.22271601

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Back to top
Posted March 06, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, Yuparat Jantraphakorn, Natthakarn Mingngamsup, Paul V Licciardi, Kulkanya Chokephaibulkit
medRxiv 2022.03.03.22271601; doi: https://doi.org/10.1101/2022.03.03.22271601
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area